Iressa 250mg - Gefitinib Tablets

Iressa 250mg - Gefitinib Tablets

4402.70 INR

Product Details:

  • Drug Type External Use Drugs
  • Physical Form Tablets
  • Function Non-Small Cell Lung Cancer
  • Dosage 250mg
  • Suitable For Teenagers, Women, Adults, Aged Person
  • Storage Instructions Dry Palace
  • Supply Ability : 100 Box Per Day
  • Click to view more
X

Price And Quantity

  • 4402.70 INR
  • 10 Box

Product Specifications

  • External Use Drugs
  • Teenagers, Women, Adults, Aged Person
  • Non-Small Cell Lung Cancer
  • 250mg
  • Dry Palace
  • Tablets

Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Cheque, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union
  • 100 Box Per Day
  • 1 Week
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

USES

Iressa is used to treat some people with non-small cell lung cancer (NSCLC). It only works for cancers that have an abnormal form of a protein called epidermal growth factor receptor (EGFR). Tests are done on the cancer cells from a lung biopsy or previous surgery to check the level of EGFR.

IRESSA COMMON SIDE EFFECTS :

Acne; diarrhea; dry skin; loss of appetite; mouth ulcers; nausea; unusual weakness; vision problems; vomiting; weight loss.

Seek medical attention right away if any of these severe side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the eyelids, mouth, face, lips, or tongue); cough; dark urine; dizziness; eye irritation or pain; extreme fatigue; fever; persistent diarrhea; stomach pain; swelling of the ankles or feet; yellowing of the skin or eyes.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anticancer Drugs' category



Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.